A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
A2 Biotherapeutics Inc.
Arvinas Inc.
Revolution Medicines, Inc.
GlaxoSmithKline
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Esperas Pharma Inc.
NextCure, Inc.
NantCell, Inc.
NextCure, Inc.
Klus Pharma Inc.
Kineta Inc.
University of Arkansas
Lumos Pharma
Petra Pharma
Xuanwu Hospital, Beijing
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
University of Utah
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
Julius-Maximilians University